NEW YORK, Dec. 29, 2010 /PRNewswire/ — Reportlinker.com
announces that a new market research report is available in its
catalogue:
Molecular Diagnostics in Cancer Testing
http://www.reportlinker.com/p0171427/Molecular-Diagnostics-in-Cancer-Testing.html
Molecular diagnostics is a rapidly-advancing area of research
and medicine, with new technologies and applications being
continually added. The technologies that come under the umbrella of
molecular diagnostics include first-generation amplification, DNA
probes, fluorescent in-situ hybridization (FISH), second-generation
biochips and microfluidics, next-generation signal detection,
biosensors and molecular labels, and gene expression profiling
using microarrays. These technologies are improving the discovery
of therapeutic molecules for cancer, the screening, diagnosis and
classification of cancer patients, and the optimization of drug
therapy. This TriMark Publications report describes the specific
segment of the in vitro diagnostics (IVD) market known as molecular
diagnostics (MD), with a specialization in the MD tests for cancer.
In the current medical diagnostics market, molecular diagnostics
for cancer testing offers one of the brightest areas for growth and
innovation. The confluence of breakthroughs in genomics,
proteomics, and the development of microarray devices to measure
analytes in the blood and various body tissues, has led to this
revolutionary market segment offering the power of advanced
analytical techniques to the diagnosis and treatment of cancer.
This report analyzes the size and growth of the molecular
diagnostics market in its applications for cancer detection and
therapy, examining the factors that influence the va
‘/>”/>
